MyAverix Finance
HK · Healthcare
Jacobio Pharmaceuticals Group Co Lt (1167)
Biotechnology
Jacobio Pharmaceuticals Group Co Lt (1167) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $4.16B, P/E ratio is 18.00, net margin is -272.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1167
Jacobio Pharmaceuticals Group Co Lt (1167) — FAQ
What is Jacobio Pharmaceuticals Group Co Lt's market cap?
Jacobio Pharmaceuticals Group Co Lt (1167) has a reported market cap of $4.16B (data as of 2026-05-21).
What is 1167's P/E ratio?
The price-to-earnings (P/E) ratio for Jacobio Pharmaceuticals Group Co Lt (1167) is 18.00 (data as of 2026-05-21).
Does Jacobio Pharmaceuticals Group Co Lt pay a dividend?
Dividend yield is not available in the current snapshot for Jacobio Pharmaceuticals Group Co Lt (1167). Check the MyAverix Finance app for the latest dividend data.
What sector is Jacobio Pharmaceuticals Group Co Lt in?
Jacobio Pharmaceuticals Group Co Lt (1167) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1167 listed on?
1167 is listed on HK.
What is Jacobio Pharmaceuticals Group Co Lt's net margin?
Jacobio Pharmaceuticals Group Co Lt (1167) reports a net margin of -272.7% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.